012790 — Sinil Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapContrarian

Annual cashflow statement for Sinil Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	7,544	6,679	12,157	13,641	14,301
Depreciation
Amortisation
Non-Cash Items	2,424	3,047	4,064	3,589	3,685
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-3,339	-3,099	-6,965	-7,437	-903
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	11,062	11,163	13,688	15,154	22,689
Capital Expenditures	-8,471	-3,629	-9,329	-12,921	-8,468
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-138	-3,036	-5,551	1,601	-15,005
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-8,609	-6,665	-14,880	-11,319	-23,473
Financing Cash Flow Items	—	—	—	92	-24
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,255	-1,347	-1,319	-1,248	-2,136
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,188	3,176	-2,396	2,576	-2,876